Diabetes decisions — 2026

The Veteran's PTSD is rated at 70 percent, but no higher. The other conditions are granted with service connection based on in-service exposure.

The Veteran's initial rating for hypertension prior to October 16, 2024 was denied. From October 16, 2024 onwards, a higher than 10 percent rating for hypertension is also denied. The claim for TDIU has been denied.

The Board has remanded the claims of service connection for a heart condition, chronic kidney disease, diabetes mellitus type II, and hypertension due to insufficient evidence regarding their etiology.

The Veteran was diagnosed with new onset diabetes during active duty training at Ft. Jackson in February 1996, and the Board granted service connection for this condition.

The Board has found that new evidence was submitted and is remanding the claims for further development to obtain medical opinions addressing whether the Veteran's diabetes mellitus and pulmonary fibrosis are caused or aggravated by his service-connected PTSD, with a focus on quetiapine.

The Board has granted service connection for obstructive sleep apnea as secondary to the Veteran's service-connected diabetes mellitus type II.

The Veteran's claim for service connection for asthma was denied.,The Veteran's claim for service connection for diabetes mellitus, type 2 is being remanded due to duty-to-assist errors.

The Board dismissed the appeal due to a withdrawal request from the appellant's authorized representative.

The Veteran's PTSD is rated at 50% from July 28, 2017. The pre-diabetic disability has not been found to be related to service exposure.

The Board has remanded the Veteran's claims due to incomplete development and the need for additional medical opinions. The issues include service connection for numbness of the mouth and jaw, hypertension, diabetes mellitus, type II, allergic rhinitis, sinusitis, and a gastroesophageal disorder.

The Veteran's diabetes mellitus, type II and kidney cancer are granted service connection due to exposure to herbicide agents, including Agent Orange. The prostate condition is denied as not related to the claimed exposure.

The Board denied the Veteran's claims of service connection for diabetes mellitus, type I; muscle and joint pains with spasms; chronic fatigue syndrome; and cardiovascular disorder. The Board found that there was no current disability related to these conditions, nor did they find a causal relationship between any service-connected disabilities and these conditions.

The Board has granted an earlier effective date of December 28, 2017 for the grant of a 40 percent rating for peripheral neuropathy with involvement of the sciatic nerve in both lower extremities associated with diabetes type II.

The Board has found that additional development is necessary before the claims for service connection for diabetes mellitus and dysautonomia can be adjudicated on the merits. The issues have been remanded to obtain missing VA treatment records from the VistA Imaging system, determine Navy Submarine Patrol Reports, and assess Agent Orange exposure.

The Board has decided to remand the case due to insufficient evidence regarding the relationship between diabetes mellitus and service.

The Veteran's claims for service connection for hypertension, diabetes mellitus type II, and related peripheral neuropathy have been denied as there is no evidence of in-service exposure to herbicide agents or other causative factors.

The Board has remanded the claims for hypertension, heart disease, and diabetes mellitus type II due to insufficient evidence of toxic exposure during service. The Veteran's participation in a TERA involving fuel and chemical exposure on the USS Lexington is unclear.

The reduction of the evaluation from 20 percent to 10 percent for Diabetes Mellitus, Type II was improper and has been restored.,Entitlement to a total disability rating based on individual unemployability (TDIU) is granted.

The Veteran's cause of death, including pneumonia and COPD, is being remanded to determine if it was due to exposure to jet fuel during service.

The Board has remanded the claim of service connection for diabetes mellitus, including as secondary to service-connected hypertension due to errors in the previous decision and a need for additional medical opinion.